Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF

Summary

The purpose of this study is to evaluate dyspnea improvement and other parameters of efficacy and safety in acute heart failure (AHF) patients receiving an intravenous (IV) infusion of clevidipine in comparison to standard of care (SOC) and placebo.

Timeline

Start

2014-08

Primary completion

2016-02

Completion

2016-11

Outcome

Outcome not reported

Stopped: “Product was divested to Chiesi USA, who decided to not move forward with study.”

Drugs

Indications